Non-Invasive Prenatal Testing Market to Reach $10.88 Billion by 2027; Technological Intervention has Played a Massive Role in Market Growth, says Fortune Business Insights™ – GlobeNewswire

Non-Invasive Prenatal Testing Market to Reach $10.88 Billion by 2027; Technological Intervention has Played a Massive Role in Market Growth, says Fortune Business Insights™ – GlobeNewswire

Pune, Sept. 14, 2020 (GLOBE NEWSWIRE) — The global Non-Invasive Prenatal Testing market size is projected to reach USD 10.88 billion by the end of 2027. The presence of several large scale companies will have a positive impact on the growth of the market in the coming years.

According to a report published by Fortune Business Insights, titled “Non-Invasive Prenatal Testing (NIPT) Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments, and Consumables & Reagents), Technology (Next Generation Sequencing, Microarray, PCR, and Rolling Circular Amplification), End User (Hospitals, and Clinical Laboratories) Regional Forecast, 2020-2027,” the market was worth USD 2.95 billion in 2019 and will exhibit a CAGR of 17.8% during the forecast period, 2020-2027.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/non-invasive-prenatal-testing-market-100998

Non-Invasive Prenatal Testing (NIPT) are used to analyze cell-free fetal DNA that detects whether the fetus will be born with certain genetic abnormalities. This process analyzes small fragments of a DNA that circulate in the blood of a pregnant woman. NIPT is described as non-invasive as only the blood of the pregnant woman is studied and it possesses no risk to the fetus. The massive investments in the development of efficient NIPT tools will bode well for the growth of the overall NIPT market in the foreseeable future.

The presence of several large scale companies operating in several countries across the world will have a huge impact on the growth of the overall market in the foreseeable future. The reducing costs of genetic testing will bode well for the growth of the NIPT market in the coming years.

Covid-19 Pandemic to Have a Minimal Impact on NIPT Manufacturers

The Covid-19 pandemic has had an adverse effect on several industries across the world. The efforts taken to curb the spread of the disease have had a damaging impact on several industries across the world. The rapidly rising cases of coronavirus across the world have urged healthcare professionals to focus on tools associated with the treatment of the disease and deviated attention from other concepts such as NIPT. As a result, the Covid-19 pandemic has had a minimal impact on the non-invasive prenatal market in the past few months.

Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998

Increasing Number of Company Mergers and Acquisitions will have a Huge Impact on Market Growth

The report encompasses several factors that have contributed to the growth of the overall market in recent years. Among all factors, the increasing number of company collaborations has made the highest impact on market growth. In March 2019, Natera announced that it has formed a strategic partnership with QIAGEN.

Through this collaboration, the company will look to develop a breakthrough cell-free DNA assays. The companies will look to capitalize on QIAGEN’s GeneReader NGS System. Such collaborations are aimed at advancing in the NIPT sector and companies will look to maximize the use of technologically advanced concepts. Natera’s collaboration with QIAGEN is among the major company collaborations of recent times that have had a major say on the growth of the overall market.

North America to Emerge Dominant; Presence of Several Diagnostic Centres to Aid Growth

The report analyses the ongoing market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years.  The increasing penetration of non-invasive prenatal testing will bode well for the growth of the regional market.

The increasing incidence of down syndrome among babies, especially in the United States will have a massive impact on the growth of the regional market. The increasing investments in the research and development of efficient NIPT by large scale companies in this region will emerge in favor of market growth. As of 2019, the market in North America was worth USD 1.52 billion and this value is projected to increase further in the coming years.

Quick Buy –  Non-Invasive Prenatal Testing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100998

List of companies profiled in the Non-Invasive Prenatal Testing Market report:

  • Illumina, Inc.  (U.S.)
  • YOURGENE HEALTH (U.K.)
  • Natera   (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • PerkinElmer Inc. (U.S.)
  • Laboratory Corporation of America (U.S.)
  • Eurofins LifeCodexx GmbH (Germany)
  • Others

Industry Developments:

July 2019: Invitae announced that it will be acquiring Singular Bio, a company specializing in single-molecule cell-free DNA analysis. The collaboration will be aimed at developing non-invasive prenatal test.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/non-invasive-prenatal-testing-market-100998

Table of Contents:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Technological Advancements in Non-Invasive Prenatal Testing (NIPT) Techniques
    • Number of NIPT Tests Performed, Key Regions, 2019
    • Impact of COVID-19 on Non-Invasive Prenatal Testing Market
    • Key Industry Developments – Mergers, Acquisitions, Etc.
  • Global Non-Invasive Prenatal Testing (NIPT) Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Consumables & Reagents
      • Instruments
    • Market Analysis, Insights and Forecast – By Technology
      • Next Generation Sequencing (NGS)
      • Microarray
      • Polymerase Chain Reaction (PCR)
      • Rolling Circular Amplification
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals
      • Diagnostic Laboratories
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/non-invasive-prenatal-testing-market-100998

Have a Look at Related Reports:

Botulinum Toxin Market Share and Global Trend By Application (Therapeutics, Aesthetics), By End User(Specialty & Dermatology Clinics, Hospitals & Clinics), By Type(Botulinum Toxin Type A, Botulinum Toxin Type B) and Geography Forecast till 2026

Next-Generation Sequencing (NGS) Market Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026

U.S. Biosimilars Market Share and Global Trend By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, Others), By Disease Indication (Cancer, Autoimmune Diseases, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026

Molecular Diagnostics Market Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025

Digital Radiography Market Share and Global Trend By Product Type (Computed Radiography, Direct Digital Radiography), Application (General, Radiography Dentistry, Oncology, Orthopedic) End User (Hospital, Clinics, Diagnostic Centers) and Geography Forecast till 2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/global-non-invasive-prenatal-testing-market-10207

Tags:

Share this post

Post Comment